T cell activation: differences in the signals required for IL 2 production by nonactivated and activated T cells
- PMID: 3934263
T cell activation: differences in the signals required for IL 2 production by nonactivated and activated T cells
Abstract
Soluble antibodies against the T3/antigen receptor complex alone are not sufficient to induce proliferation and interleukin 2 expression by T lymphocytes. An additional requirement is the presence of accessory cells (AC). In this model, AC provide at least two functions required for T cell activation: 1) the surface interaction of T3 antibodies with Fc receptors on the AC surface and 2) the production of soluble mediators such as interleukin 1 (IL 1). In the experiments reported here, these stimuli are represented by T3 antibodies immobilized onto Sepharose beads and by recombinant IL 1. In this study we investigated differences in activation requirements in resting and activated T cells. Resting T cells were represented by AC-depleted peripheral blood mononuclear cells (PBMC) or the T cell line Jurkat, which phenotypically resembles a resting T cell. Activated T cells were represented by T cell clones and the T cell line HUT 78, which express the activation molecules Ia and the IL 2 receptor (Tac). In resting cells, activation required the presence of three different signals: perturbation of the T3/antigen receptor complex by T3 antibodies, surface redistribution of T3/antigen receptor complexes, and presence of IL 1. In contrast, activated T cells require only perturbation and redistribution of T3/antigen receptor complexes and not IL 1 for the induction of proliferation or IL 2 production. Possible mechanisms of intracellular signaling for these stimuli are discussed.
Similar articles
-
Mechanisms by which accessory cells contribute in growth of resting T lymphocytes initiated by OKT3 antibody.Eur J Immunol. 1985 Jul;15(7):645-51. doi: 10.1002/eji.1830150702. Eur J Immunol. 1985. PMID: 3924633
-
Requirements for T cell activation by OKT3 monoclonal antibody: role of modulation of T3 molecules and interleukin 1.J Immunol. 1985 Sep;135(3):1714-8. J Immunol. 1985. PMID: 3926880
-
The role of interleukin 2 and T11 E rosette antigen in activation and proliferation of human NK clones.J Immunol. 1985 Jul;135(1):672-8. J Immunol. 1985. PMID: 3923116
-
The multichain interleukin-2 receptor: a target for immunotherapy of patients receiving allografts.Am J Kidney Dis. 1989 Nov;14(5 Suppl 2):45-53. Am J Kidney Dis. 1989. PMID: 2683757 Review.
-
Two pathways of T cell activation.Behring Inst Mitt. 1987 Jun;(81):15-30. Behring Inst Mitt. 1987. PMID: 3115246 Review.
Cited by
-
Induction of cytotoxicity in resting human T lymphocytes bound to tumor cells by antibody heteroconjugates.Proc Natl Acad Sci U S A. 1987 Jul;84(13):4611-5. doi: 10.1073/pnas.84.13.4611. Proc Natl Acad Sci U S A. 1987. PMID: 3110771 Free PMC article.
-
Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen.J Exp Med. 1988 May 1;167(5):1572-85. doi: 10.1084/jem.167.5.1572. J Exp Med. 1988. PMID: 3259252 Free PMC article.
-
Differences in the stimulating capacity of immobilized anti-CD3 monoclonal antibodies: variable dependence on interleukin-1 as a helper signal for T-cell activation.Immunology. 1991 Feb;72(2):269-76. Immunology. 1991. PMID: 1826671 Free PMC article.
-
Interleukin-1 function and role in rheumatic disease.Nat Rev Rheumatol. 2016 Jan;12(1):14-24. doi: 10.1038/nrrheum.2016.166. Epub 2015 Dec 10. Nat Rev Rheumatol. 2016. PMID: 26656658 Review.
-
Immunomodulatory effects of therapeutic gold compounds. Gold sodium thiomalate inhibits the activity of T cell protein kinase C.J Clin Invest. 1992 Jun;89(6):1839-48. doi: 10.1172/JCI115788. J Clin Invest. 1992. PMID: 1351061 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources